Tonix Pharmaceuticals (NASDAQ:TNXP) Upgraded by Wall Street Zen to “Hold” Rating
Wall Street Zen upgraded shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. TNXP has been the topic of several other research reports. Noble Financial reaffirmed an “outperform” rating and set a $70.00 price target on shares of Tonix […]
Wall Street Zen upgraded shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. TNXP has been the topic of several other research reports. Noble Financial reaffirmed an “outperform” rating and set a $70.00 price target on shares of Tonix […]
